Secondhand smoke is an important modifiable risk factor in sickle cell disease: A review of the current literature and areas for future research
Abstract
© 2016 by the authors; licensee MDPI, Basel, Switzerland.Sickle cell disease (SCD)
is an autosomal recessive hemoglobinopathy that causes significant morbidity and mortality
related to chronic hemolytic anemia, vaso-occlusion, and resultant end-organ damage.
Tobacco smoke exposure (TSE) through secondhand smoke exposure in people with SCD
of all ages and through primary smoking in adolescents and adults is associated with
significantly increased morbidity, with increased rates of emergency department visits
and hospitalizations for painful vaso-occlusive crises and acute chest syndrome (ACS).
Secondhand smoke is also associated with pulmonary function abnormalities in children
with SCD who are already at risk for pulmonary function abnormalities on the basis
of SCD. TSE is emerging as one of the few modifiable risk factors of SCD. This review
discusses the current state of the evidence with respect to TSE and SCD morbidity,
discusses potential mechanisms, and highlights current gaps in the evidence and future
research directions.
Type
Journal articlePermalink
https://hdl.handle.net/10161/13333Published Version (Please cite this version)
10.3390/ijerph13111131Publication Info
Sadreameli, S Christy; Kopp, Benjamin T; Creary, Susan E; Eakin, Michelle N; McGrath-Morrow,
Sharon; & Strouse, John J (2016). Secondhand smoke is an important modifiable risk factor in sickle cell disease: A
review of the current literature and areas for future research. International Journal of Environmental Research and Public Health, 13(11). 10.3390/ijerph13111131. Retrieved from https://hdl.handle.net/10161/13333.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
John J. Strouse
Associate Professor of Medicine
My research has focused on the epidemiology, risk factors, and prevention of the pulmonary
and central nervous system complications of sickle cell disease and includes retrospective
and prospective cohort studies and clinical trials. I received my Ph.D. in clinical
investigation from the Johns Hopkins Bloomberg School of Public Health for a series
of studies to identify predictors of cognitive function in children with sickle cell
disease. This work has expanded to the evaluation

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info